Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Convergent Combination Immunotherapy for the Prevention and Treatment of SARS

Convergent Combination Immunotherapy for the Prevention and Treatment of SARS. The 5th International Congress on Recombinant Antibodies. Zurich, Switzerland. 2006.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.